Abstract
Topical therapy is important in the treatment of actinic keratosis (AK), a major risk factor for, and early development stage of, squamous cell carcinoma. Despite this, research addressing the limitations and challenges associated with topical field therapy in actinic keratosis is lacking.
Lingua originale | English |
---|---|
pagine (da-a) | N/A-N/A |
Rivista | Journal of the European Academy of Dermatology and Venereology |
DOI | |
Stato di pubblicazione | Pubblicato - 2014 |
Keywords
- actinic keratosis